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Differentiation of cells in different tissues follows similar rules,
although it involves different tissue-speciﬁc genes, proteins, and
extracellular matrix components. In tissues such as skin, he-
matopoietic cells, intestinal mucosa, and the glands of prostate
and bronchus, cell renewal is dependent on the presence and
continual proliferation of tissue-speciﬁc stem cells, which
reside in speciﬁc histological locations, clearly visible under
microscopic examination. Bone marrow hematopoietic stem
cells, although not easily identiﬁable in tissue sections, can be
easily separated and studied using cell-sorting methods.
The sole role of tissue-speciﬁc stem cells is the mainte-
nance of the needed numbers of the fully differentiated
epithelial cells, which are the hallmark of the organ’s
identity and function. Cells derived from such tissue-
speciﬁc stem cells, or progenitor cells, are not yet fully
differentiated but continue to proliferate toward the terminal
differentiated phenotype. Studies in liver growth biology
have been tackling such issues, and much new knowledge
has emerged. The article by Sekiya and Suzuki1 in this issue
of The American Journal of Pathology highlights the
complexity of hepatic biology in the context of liver growth.
Despite several discussions concerning the existence and
nature of liver-speciﬁc stem cells2 and identiﬁcation of isolated
candidate cells with aberrant biomarkers by electron micro-
scopy or immunohistochemistry,3 there is no concrete evi-
dence of a histologically demonstrable location for stemcells in
hepatic lobules. Moreover, studies have shown that all mature
and fully differentiated liver cell types participate in liver
regeneration after partial hepatectomy, without the interven-
tion of stem cells,4,5 raising questions about their existence.
Progenitor Cells and Their Origins from Biliary
Epithelium
In view of the failure of classic histological approaches to
identify a speciﬁc and easily demonstrable lobular location for
hepatic stem cells, other molecular approaches have beenCopyright ª 2014 American Society for Investigative Pathology.
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erate by generating another tissue-speciﬁc stem cell and a
progenitor cell, which continue to proliferate and derive the
ﬁnally differentiated epithelial cells of the organ. Thus,
administration of the DNA-labeling agent, bromodeoxyur-
idine (BrdU), results in long-term labeling of the tissue-
speciﬁc stem cells, whereas the label is diluted from the mul-
tiple sequential proliferation cycles of the progenitor cells. By
using this approach, Theise and colleagues6 demonstrated
BrdU-retaining cells in biliary ductules and the immediate
proximate periportal hepatocytes. Although these cells retain
BrdU for a long period, they cannot be viewed as tissue-
speciﬁc stem cells because they perform routine differenti-
ated functions for the organ (eg, proteins speciﬁc to hepatocyte
differentiation and lining of mature bile ductules).
Hepatocytes play an essential role in liver regeneration
after partial hepatectomy. Hepatocytes undergo the neces-
sary number of proliferation cycles, as well as produce
paracrine signals, which stimulate proliferation of other liver
cells, which, in turn, use growth factors and cytokines to
further enhance hepatocyte proliferation.5,7 Inhibition of
hepatocyte proliferation after partial hepatectomy results in
the appearance of a new population of cells, called oval cells
because of the shape of their nucleus.8 Pioneering studies by
Thorgeirsson and his collaborators, using thymidine pulse
labeling, identiﬁed biliary epithelial cells as the origin of
oval cells. Soon after their appearance, oval cells continue to
express biliary biomarkers, while at the same time initiating
albumin and a-fetoprotein production. This is associated
with the expression of hepatocyte-speciﬁc transcription
factors in the biliary epithelial cells.9e11 Toxic damage to
Michalopoulosthe biliary cells before the initiation of the oval cell process
eliminates the appearance of the oval cells.12
Oval cells gradually increase in size, convert to small
hepatocytes, and eventually become regular hepatocytes,
thus providing the necessary number of hepatocytes needed
to complete regeneration. Several elegant studies have
demonstrated the supporting role of hepatic stellate cells,
growth factors, such as hepatocyte growth factor (HGF),
and epidermal growth factor receptor (EGFR) ligands, and
changes in extracellular matrix during the conversion of
biliary epithelial cells to hepatocytes via the oval cell
pathway.9e11 Although oval cells are not derived from a
tissue-speciﬁc stem cell, they are classiﬁed as progenitor
cells.
The progression of biliary cells to progenitor cells is a
complex process in which speciﬁc receptors and tissue-
based growth factors appear. TheWnt-related protein LGR5,
a receptor for Rspo1, is expressed in intestinal stem cells.
Although it is not expressed in mature adult liver, it is
expressed after damage of the biliary epithelium. Organoid
cultures derived from Lgr5-expressing cells and under the
inﬂuence of Rspo1-generated progenitor cells that were
transdifferentiating into hepatocytes in the Fah/ mouse
liver recolonization model.13 It would be interesting to
examine if Lgr5 is expressed in the biliary cells early in their
transformation to progenitor cells. This discovery suggests
that the progenitor cells, although having a biliary origin
and a hepatocyte destination, can proceed through gene
expression and cell proliferation rules of their own until they
achieve their ﬁnal objective.
Most of the early studies on progenitor cellswere conducted
in rats, using the model of suppressed liver regeneration after
partial hepatectomy with simultaneous administration of the
carcinogenic chemical 2-acetylaminoﬂuorene (AAF).9,11 The
administration of AAF causes DNA adduct formation and
activation of Cdkn1a-dependent (alias p21) and Trp53-
dependent pathways, thus blocking hepatocyte proliferation.
AAF induces DNA adducts in rat hepatocytes because of the
presence of the enzyme N-sulfotransferase, which generates
sulfate salts with the activated form of AAF, the N-OH AAF
radical, thus allowing it to migrate to the nucleus before
becoming inactivated by glutathione in the cytoplasm.14
However, N-sulfotransferase does not exist in the mouse14
and AAF is a weak mouse carcinogen and it does not block
liver regeneration. Therefore, many investigators, including
Sekiya and Suzuki,1 use the 3,5-diethoxycarbonyl-1,4-
dihydrocollidine (DDC) diet in mouse, which induces cell
death and continuing proliferation of biliary epithelial cells
associated with biliary repair. However, DDC also induces
porphyria and toxicity to hepatocytes.15 The mechanisms
causing toxicity, death, and proliferation of biliary epithelial
cells in the DDC diet are not well understood. Although oval
cells in the AAF-rat and the proliferating biliary cells in the
DDC-mice have the same origin, it is not clear whether they
both represent a progenitor cell population with the same
features and characteristics. Also, the purpose of proliferating1264biliary cells in the DDC diet is debatable, other than a local
response aimed to repair biliary epithelial cells in response to
injury. Such injury to biliary epithelial cells does not occur in
the rat AAF/partial hepatectomy model.Hepatocytes as Facultative Stem Cells for
Biliary Epithelium
Although there is little doubt about the origin of the progenitor
cells and (at least in the rat) their transition from biliary cells to
hepatocytes, the opposite pathway has been the subject of
much recent debate. In human pathology, proliferation of
biliary epithelial cells yielding well-formed ductules is a
common feature in obstructive cholangiopathies. Atypical
biliary pseudoductules appear in primary biliary cirrhosis, an
autoimmune disease associated with destruction of the intra-
hepatic biliary ductules. In all these situations, it is assumed
that the cells of origin of the proliferating ductules are sur-
viving biliary epithelial cells. There is also little doubt that
proliferating biliary epithelial cells are the origin of new
ductules formed after bile duct ligation in experimental
models. In view of this, previous suggestions that hepatocytes
may contribute to the formation of biliary ductules have met
with skepticism. Such studies have persisted, however, to
understand how the biliary epithelium can be repaired under
conditions of chronic toxic or autoimmune injury (eg, primary
biliary cirrhosis).
Studies were conducted in rats using a chimeric rat liver
in which hepatocytes of a strain of Fisher rats have a
mutated and nonfunctional enzymeddipeptidylpeptidase 4
(DPP IV). A simple histochemical assay stains DPP IVe
positive hepatocytes orange. Administration of the chemical
retrorsine to DPP IVenegative rats causes DNA cross-
linking and prevents hepatocytes from proliferation after
partial hepatectomy. Direct injection via the portal vein of
DPP IVepositive hepatocytes into the liver of retrorsine-
treated DPP IVenegative rats subjected to partial hepatec-
tomy results in a chimeric liver in which the DPP IVepositive
hepatocytes proliferate and restore liver mass.16 DPP IV
stains hepatocyte bile,17 canaliculi, and bile ductules. In the
chimeric livers, however, only hepatocytes derived from
the injected DPP IVepositive cells appeared positive,
whereas bile ductules were uniformly negative. When such
chimeric livers were subjected to bile duct ligation, a small
percentage (1.46%) of the newly proliferating bile ductules
were DPP IV positive, suggesting that it had been derived
from hepatocytes. However, when this process was per-
formed after administration of the chemical methylene
dianiline, a speciﬁc toxin to biliary epithelial cells, prolif-
erating bile ductules of the chimeric livers subjected to bile
duct ligation had a much higher percentage (53.02%) of
DPP IVepositive bile ductules.18 The study showed that,
under regular conditions, in which biliary epithelium can
repair itself, the contribution of hepatocytes to the forma-
tion of biliary ductules is small. On the other hand, underajp.amjpathol.org - The American Journal of Pathology
Commentaryconditions in which the biliary epithelium cannot repair
itself because of toxic injury, the contribution of hepato-
cytes is much more expanded and essential for the biliary
repair. The same conversion of hepatocytes to biliary
epithelial cells was demonstrated in ordinary cultures
derived from the same DPP IV chimeric livers. The per-
centage of DPP IVepositive biliary epithelial cells was the
same as the percentage of DPP IVepositive hepatocytes
introduced into the cultures.
Cell culture studies made it possible to use selective
conditions and identify growth factors and cytokines that
support this conversion. From many growth factors studied,
only HGF and the EGFR ligand EGF were able to facilitate
the transdifferentiation of hepatocytes to biliary cells, via
pathways dependent on phosphoinositide 3-kinase and Akt.
Cultures with HGF, EGF, and all of the other growth factors
were subject to analysis by gene array. HGF and EGF could
induce distinct types of gene expression patterns compared
with all other growth factors and are probably essential for
facilitating this transdifferentiation.
The studies in rats were facilitated by a naturally occurring
advantageous situation of strain tagging (and thus cell
tagging), leading to the generation of chimeric livers. Mul-
tiple subsequent studies were also initiated in mice, taking
advantage of the tools of mouse genetics and the availability
of well-characterized, hepatocyte-speciﬁc vectors. (These
previous studies are extensively discussed by Sekiya and
Suzuki.1) Various tools have been used to generate lineage
tagging, in which hepatocytes and biliary epithelial cells
could be clearly distinguished by different immunoﬂuores-
cence colors. This was on the basis of genetic manipulations
induced by expression of Cre recombinase under the control
of promoters speciﬁc to hepatocytes and biliary cells, but
different for each study. Studies by Willenbring and col-
leagues19 used hepatocyte-speciﬁc vectors. There was no
evidence of transdifferentiation of hepatocytes to ducts
composed of biliary epithelial cells. However, atypical duct-
ules carrying hepatocyte markers were occasionally seen.
These studies were performed in situations in which there was
no injury to the biliary epithelium and, thus, it was probably
able to repair itself without needed contribution by hepato-
cytes, as with the DPP IV chimeric rat model previously
described.18 They also reported that hepatocytes are a major
source of cholangiocarcinoma, a hepatic malignancy
composed of neoplastic biliary cells,20 suggesting that this
transdifferentiation is frequent enough to lead to biliary cells of
sufﬁcient numbers that can stochastically become the source of
cholangiocarcinomas. Because typically only a small per-
centage of any cell pool accumulates sufﬁcient chronic alter-
ations to becomemalignant, results suggest that the conversion
of hepatocytes to biliary epithelial cells is much more frequent
than envisioned in their earlier study.
By using the DDC model, Stanger and collueages21 found
that approximately 14% of the biliary cells were derived
from hepatocytes. Stanger and colleagues21 also found that
biliary-associated markers were expressed in hepatocytes inThe American Journal of Pathology - ajp.amjpathol.orgthe DDC diet, thus allowing for the possibility that the
origin of the biliary ductules with hepatocyte markers was
derived from altered hepatocytes. However, the observa-
tions by Stanger and colleagues21 are fully consistent with
previous observations from human pathology, in which
biliary biomarkers are expressed in human hepatocytes in
several cholangiopathies (and vice versa).22
Sekiya and Suzuki1 used approaches intended to over-
come previous concerns, by tagging hepatocytes and biliary
cells many days before administering the DDC diet. Their
results unambiguously demonstrate that when biliary
epithelial viability is impaired (by the DDC diet), many of
the emerging new ductules derive from hepatocytes. This
was not seen in regular liver regeneration after partial hep-
atectomy or simple chemical injury by CCl4. The authors
used many approaches to eliminate the possibility that
transient albumin expression by the cholangiocytes could
trigger activation of the Cre recombinase and generate a
false impression of derivation from hepatocytes.1 However,
results show that when the DDC injury was withdrawn, the
percentage of hepatocyte-derived biliary cells dramatically
decreased, suggesting that these ductules are seen as
different from the native ductules derived from biliary
epithelial cells. However, the reasons remain unclear. The
signiﬁcance of this ﬁnding from a perspective of human
disease is probably small, because in most human diseases
that trigger the conversion of hepatocytes to biliary cells, the
injurious stimuli do not go away. The authors also found that
Notch and Hes-1 are involved in this transdifferentiation,
something that comes as no surprise given the extensive
literature linking Notch to the formation of the biliary tree
during embryonic development.23Clarity and Controversies: Genetic Lineage
Tagging
Despite established in vivo and in vitro transdifferentiation of
hepatocytes to biliary cells, the studies in the mouse have
generated different points of view and considerable contro-
versy, which may reﬂect a justiﬁed and often expressed
skepticism about the apparent clarity of cell lineage tagging
studies in mouse. Although the studies done in rats depend on
a naturally occurring and stable cell tagging mutation of an
enzyme, lineage tagging studies in mice depend on expres-
sion of promoters used for the genetic manipulation. The
functions and cellular speciﬁcities of most of these promoters
are not fully understood. By using lineage tagging of biliary
cells, Furuyama et al24 demonstrated that, during the course
of a mouse’s life, there is progressive replacement of hepa-
tocytes by other hepatocytes derived from biliary epithelial
cells. They showed that the same phenomenon occurs in the
pancreas. By using a similar lineage tagging approach,
Lemaigre and colleagues25 demonstrated that there was no
such replacement, with the exception of immediate periportal
hepatocytes.19 It is difﬁcult to reconcile such opposing results1265
Michalopoulospurely on the basis of promoter function per se. Because these
approaches often depend on inserting a new genetic element
in the mouse DNA, it is conceivable that the location of the
transgene in the genome (usually not identiﬁed) may be
proximate to other genes whose function is inadvertently
modiﬁed, causing results not related to the innate function of
the promoter or the transgene. In the study by Furuyama
et al,24 it is possible that hepatocytes may have acquired a
block that inhibits the amount of cell proliferation required
for simple maintenance of hepatocyte numbers required for
the maintenance of the organ. If this were to be the case, then
the biliary cells would be activated to slowly replace hepa-
tocytes, as in the AAF/partial hepatectomy model in the rat.
The existence of transdifferentiation patterns between
biliary cells and hepatocytes should come as no surprise.
Both of the cell types derive in embryonic development
from hepatoblasts. The latter cells carry a predominantly
hepatocytic gene expression pattern. The lineage split be-
tween hepatocytes and biliary cells occurs late in embryonic
development in the rodents.25 Thus, it should be expected
that interconversions of phenotype should be rather easy.
This is seen when hepatocytes are placed in primary culture.
Within 2 to 3 days of culture, hepatocytes begin expressing
biomarkers characteristic of biliary epithelial cells.26 Recent
studies have also shown that at the point where the canals of
Hering come into contact with hepatocytes deep in the
lobule, there are cells expressing transcription factors and
biomarkers common to both cell types.27 Thus, such cells
seem to pre-exist, but it is not clear whether they exist in
numbers that would be a sufﬁcient source to generate all or a
portion of the progenitor cells. In addition, biliary cells of
mature intrahepatic ductules do acquire hepatocyte-speciﬁc
transcription factors soon after initiation of the AAF/par-
tial hepatectomy model. However, as Sekiya and Suzuki1
point out, progenitor cells often arise deep in the lobule,
as far as pericentral regions, depending on the toxin causing
the hepatic damage. It is possible that the biliary cells of the
portal ductules are the source of oval cells arising in peri-
portal locations, whereas progenitor cells arising in peri-
central regions of the lobule may derive from pre-existing
cells of mixed differentiation deep in the canals of Hering.Implications for Regenerative Mechanisms in
Liver Failure
The ﬁndings in animal models also have implications for
human liver disease. Expression of biliary transcription fac-
tors in hepatocytes is seen in human cholangiopathies.
Conversely, expression of hepatocyte-associated transcription
factors in biliary cells is seen in chronic diseases associated
with continual hepatocyte death.22 Even more revealing are
liver histological characteristics in human fulminant hepatic
failure. It shows many regenerative clusters composed of cells
with mixed hepatocytic and biliary differentiation.28 It is not
clear which way the transdifferentiation is proceeding in these1266clusters. The overall huge number of proliferating biliary
epithelial cells rampantly expressing hepatocyte-associated
transcription factors suggests that the regenerative clusters
in the proliferating biliary epithelium support an SOS mech-
anism to repair a rapidly declining organ. A fraction of cases
of fulminant hepatic failure, as much as 30%, spontaneously
recover. There is no evidence that the cases of spontaneous
recovery are associated with these regenerative clusters. It is
unfortunate that little histological material exists from such
cases because of the difﬁculty of performing biopsies, with all
of the coagulopathies and the associated high morbidity. Most
of our knowledge about these clusters of transdifferentiation
comes from livers removed in the course of orthotopic liver
transplantation. It is of interest that, in these clusters, the re-
ceptors for HGF and EGF are widely expressed, but their
activation is only seen in the hepatocyte component of the
clusters. Little cell proliferation is seen, suggesting that the
effect of these mitogenic receptors is not aimed at cell pro-
liferation but rather toward control of cell differentiation. This
ﬁnding is reminiscent of the critical role that these two re-
ceptors play in control of transdifferentiation seen in organoid
cultures, as previously mentioned. The high expression of
receptor FAS and the growth inhibitor GPC329 in these
clusters may play a regulatory role.
Summary and General Considerations
It is now clear that when it comes to stem cell biology, liver
is a bipolar organ. Committed, liver-speciﬁc stem cells, with
no other function than their stemness, do not appear to exist
in liver, as in intestine and skin. Biliary cells and hepato-
cytes can function as facultative stem cells for each other if
one of the two cell systems is incapable of repairing itself in
situations that are critical for the survival of the organ.
Although seemingly paradoxical, it does have advantages
related to organ survival. The existence of many facultative
stem cells allows for quick recovery because only a few
proliferative events are needed to provide sufﬁcient numbers
or progenitor cells for effective repair. This is not the case
for tissue-speciﬁc stem cells, each one of which needs to
proliferate multiple times to generate sufﬁcient numbers of
progenitor cells. All liver-speciﬁc regenerative pathways,
most of them extreme compared with other organs, have
been honed by evolution to allow for quick recovery of an
organ vital for the survival of the organism.
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